These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20025594)

  • 21. Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.
    Schorlemmer HU; Dickneite G
    Ann N Y Acad Sci; 1993 Jun; 685():155-74. PubMed ID: 8363220
    [No Abstract]   [Full Text] [Related]  

  • 22. Susceptibility to oil-induced arthritis in the DA rat is determined by MHC and non-MHC genes.
    Lorentzen JC; Olsson T; Klareskog L
    Transplant Proc; 1995 Apr; 27(2):1532-4. PubMed ID: 7725401
    [No Abstract]   [Full Text] [Related]  

  • 23. IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis.
    Pöllinger B
    J Mol Med (Berl); 2012 Jun; 90(6):613-24. PubMed ID: 22231742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models of rheumatoid arthritis: How informative are they?
    McNamee K; Williams R; Seed M
    Eur J Pharmacol; 2015 Jul; 759():278-86. PubMed ID: 25824900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanized animal models for autoimmune diseases.
    Gregersen JW; Holmes S; Fugger L
    Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
    Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
    BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redirecting Th1 and Th2 responses in autoimmune disease.
    Pearson CI; McDevitt HO
    Curr Top Microbiol Immunol; 1999; 238():79-122. PubMed ID: 10087651
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor necrosis factor and interferon gamma: relevance for immune regulation and genetic predisposition to autoimmune disease.
    Jacob CO
    Semin Immunol; 1992 Jun; 4(3):147-54. PubMed ID: 1627786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of animal models for drug development in multiple sclerosis.
    Friese MA; Montalban X; Willcox N; Bell JI; Martin R; Fugger L
    Brain; 2006 Aug; 129(Pt 8):1940-52. PubMed ID: 16636022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
    Beebe AM; Cua DJ; de Waal Malefyt R
    Cytokine Growth Factor Rev; 2002; 13(4-5):403-12. PubMed ID: 12220553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics.
    Lazúrová I; Jochmanová I; Benhatchi K; Sotak S
    Immunol Res; 2014 Dec; 60(2-3):193-200. PubMed ID: 25427993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A chimeric cytokine to help autoimmune diseases].
    Rafei M; Galipeau J
    Med Sci (Paris); 2010 Feb; 26(2):137-9. PubMed ID: 20188040
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.
    Ockinger J; Stridh P; Beyeen AD; Lundmark F; Seddighzadeh M; Oturai A; Sørensen PS; Lorentzen AR; Celius EG; Leppä V; Koivisto K; Tienari PJ; Alfredsson L; Padyukov L; Hillert J; Kockum I; Jagodic M; Olsson T
    Genes Immun; 2010 Mar; 11(2):142-54. PubMed ID: 19865101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically validated approaches to the treatment of autoimmune diseases.
    Carter PH; Zhao Q
    Expert Opin Investig Drugs; 2010 Feb; 19(2):195-213. PubMed ID: 20050823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focusing on the human T cell receptor for antigen.
    Grunewald J
    Sarcoidosis; 1994 Mar; 11(1):61-5. PubMed ID: 8036347
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multiple sclerosis].
    Offenhäusser M; Martin R
    Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
    [No Abstract]   [Full Text] [Related]  

  • 39. Animal models of autoimmune diseases.
    Burkhardt H; Kalden JR
    Rheumatol Int; 1997; 17(3):91-9. PubMed ID: 9352602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603.
    Ohta Y; Fukuda S; Makino H
    Immunopharmacology; 1997 Oct; 37(2-3):167-74. PubMed ID: 9403335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.